arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Whitehawk Therapeutics, Inc.

WHWK
$3.84 ▼ -0.21 (-5.19%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
19 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Whitehawk Therapeutics, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $237.6M
Dividend Yield —
Revenue Growth -72.5% ↘
Op. Margin None
ROIC -83.9% ↗
FCF / Share $-1.58 ↗
Trailing P/E —
Price / Book 1.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$7.14M
↓ -72.5% —
Net Income Profit after all expenses
$-20.60M
↑ +67.7% —
Operating Margin Operating profit as % of sales
-259.6%
↑ +12.1% —
FCF / Share Free cash flow per share
$-1.58
↑ +30.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
1
Returns ↑
30
Cash Quality ↑
95

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 70 quarters